Could a poop pill boost cancer treatment? new trial tests gut bacteria transplant for stubborn colorectal cancer
NCT ID NCT07486492
First seen Apr 25, 2026 · Last updated May 10, 2026 · Updated 3 times
Summary
This early-stage study tests whether transplanting gut bacteria from young donors (fecal microbiota transplant) can make immunotherapy and chemotherapy work better for people with a hard-to-treat type of metastatic colorectal cancer (MSS mCRC). Ten patients aged 18-75 who have already tried first-line treatment will receive six bacteria transplants along with standard drugs. The main goal is to check safety, with a secondary look at whether the combination can shrink tumors or slow cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FECAL MICROBIOTA TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.